Skip to main navigation Skip to search Skip to main content

Hepatoblastoma evaluated by 18F-fluoromethyl choline PET/CT.

  • Matthanja Bieze*
  • , Thomas M. van Gulik
  • , Roelof J. Bennink
  • *Corresponding author for this work
  • University of Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)

Abstract

Hepatoblastoma is a rare carcinoma mostly seen in children. Neoadjuvant chemotherapy followed by resection and adjuvant chemotherapy is the optimal treatment. We present the case of an 18-year-old woman who presented with abdominal pain, nausea, bloating, and fatigue. MRI showed 3 hepatic lesions with high signal intensity on arterial phase T1-weighted images and slight washout on the late phase, suggestive for hepatocellular carcinoma. Laboratory examinations revealed plasma α-feto-protein of 114,245 μg/L. Subsequent baseline and posttreatment F-fluoromethyl choline PET/CT were performed to possibly evaluate extent of the disease and assess disease response after neoadjuvant chemotherapy.

Original languageEnglish
Pages (from-to)e80-82
JournalClinical Nuclear Medicine
Volume38
Issue number2
DOIs
Publication statusPublished - Feb 2013
Externally publishedYes

Fingerprint

Dive into the research topics of 'Hepatoblastoma evaluated by 18F-fluoromethyl choline PET/CT.'. Together they form a unique fingerprint.

Cite this